GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...

TeleTrader 11/7/2023 J&J to begin trials with surgical robot

TeleTrader 10/17/2023 J&J's Q3 sales up 6.8% to $21.4 billion

TeleTrader 10/3/2023 J&J's $223.8M talc powder case fine overturned

TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate

TeleTrader 7/20/2023 J&J highest since January as Q2 results top estimates

TeleTrader 7/20/2023 J&J's Q2 sales rise by 6.3% to $25.5 billion

TeleTrader 7/18/2023 J&J joins drug price suits against US gov't

TeleTrader 5/4/2023 J&J's Kenvue reportedly valued at $41B for IPO

TeleTrader 4/24/2023 J&J reportedly hopes to raise $3.5B in Kenvue roadshow

TeleTrader 4/18/2023 J&J revenue grows 5.6% to $24.75 billion in Q1

TeleTrader 4/4/2023 J&J to pay $8.9B to settle claims talc products caused cancer

TeleTrader 1/30/2023 Wall Street closes with losses as Fed, earnings loom

TeleTrader 1/30/2023 J&J to challenge bankruptcy ruling

TeleTrader 1/30/2023 J&J talc unit's bankruptcy petition in US dismissed

TeleTrader 1/24/2023 J&J's Q4 sales down 4.4% to $24B on lower COVID-19 vaccine sales

TeleTrader 1/13/2023 J&J reportedly cuts COVID vaccine production

TeleTrader 11/1/2022 Abiomed skyrockets 50% on J&J's takeover deal

TeleTrader 10/18/2022 J&J to reduce headcount despite robust sales

TeleTrader 10/18/2022 J&J's Q3 sales up 1.9% to $23.8 billion

TeleTrader 9/14/2022 J&J launches $5B share buyback program

TeleTrader 8/12/2022 J&J to stop selling talc-based baby powder in 2023

TeleTrader 7/19/2022 J&J posts Q2 EPS of $1.8, dropping 23.4% YoY

TeleTrader 5/6/2022 FDA limits J&J vaccine use due to blood clot risks